Skip to content

Tinnitus Suppression for Cochlear Implant Recipients

Evaluation of Tinnitus Suppression for Cochlear Implant Recipients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02794623
Enrollment
12
Registered
2016-06-09
Start date
2014-10-18
Completion date
2018-06-08
Last updated
2021-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Keywords

cochlear implants, hearing loss

Brief summary

Tinnitus is the perception of sound in the absence of an external sound. Prevalence in the general population is 10 to 15%, with tinnitus severely impacting quality of life in 1-2 percent of the population. Tinnitus therapy is based on counselling, cognitive and behavioural therapies in combination with sound therapies which mostly rely on masking. For cochlear implant candidates, the ability to use hearing aids and maskers is limited by the degree of their hearing loss. Reports of tinnitus prevalence in this group range from 67 to 100% with a mean of 80%. In cochlear implant (CI) recipients, tinnitus suppression primarily occurs during active use of the cochlear implant system. In some CI recipients residual inhibition of tinnitus occurs when the implant is switched off. While the benefits of CI implantation on tinnitus are well documented, there is a group of recipients where tinnitus remains a concern in the implanted ear post-operatively. The primary aim of this study is to investigate the benefits of using tinnitus masking via a CI sound processor that optimises tinnitus suppression with minimal annoyance to the user. Furthermore a questionnaire will be employed to capture the prevalence, degree and nature of tinnitus in recipients.

Interventions

Tinnitus masking via CI system

Sponsors

Royal Victoria Eye and Ear Hospital
CollaboratorOTHER_GOV
Cochlear
CollaboratorINDUSTRY
The Hearing Cooperative Research Centre
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 18 years of age or older 2. Freedom or CI500 series implant 3. At least 3 months experience with the cochlear implant 4. Native speaker in the language used to assess speech perception performance 5. Willingness to participate in and to comply with all requirements of the protocol 6. Self-reported tinnitus in the implanted ear 7. Reside local to investigational site

Exclusion criteria

1. Signs of retrocochlear or central origin to hearing impairment as confirmed by medical examination and test including MRI 2. Additional handicaps that would prevent participations in evaluations 3. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the study

Design outcomes

Primary

MeasureTime frameDescription
Tinnitus Severity QuestionnaireTesting over 6 monthsTinnitus severity questionnaire using Visual Analog Scale
Word recognition scores in quietTesting over 6 monthsMonosyllabic word scores in quiet
Speech recognition scores in noiseTesting over 6 monthsSentence recognition scores in noise

Secondary

MeasureTime frameDescription
Degree of handicap as a result of tinnitusTesting over 6 monthsTinnitus Handicap Questionnaire used to capture degree of overall handicap as a result of tinnitus

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026